WHO ICTRP trial

Evaluation of the therapeutic effects of bromelain-based supplement (Anaheal…

IRCT20230629058615N5 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting

Key facts

Trial ID IRCT20230629058615N5
Public title Evaluation of the therapeutic effects of bromelain-based supplement (Anaheal 1200 GDU enteric coated) after blepharoplasty
Scientific title Evaluation of the therapeutic effects of bromelain-based supplement (Anaheal 1200 GDU enteric coated) on ecchymosis, swelling and pain after blepharoplasty in patients over 18 years old versus placebo
Primary sponsor Islamic Azad University
Registry Iranian Registry of Clinical Trials (IRCT)
Recruitment status Not Recruiting
Study type interventional
Phase 3
Countries Iran (Islamic Republic of)
Conditions Ptosis of eyelid. Unspecified ptosis of eyelid;H02.40
Interventions Intervention 1: Intervention group: includes 25 patients over 18 years old after blepharoplasty. After checking the inclusion and exclusion criteria of the study and obtaining informed consent, patients will receive one Anaheal 1200 GDU…
Registration date Sep 15, 2024
Target size 50
Registry page irct.behdasht.gov.ir

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations